The Patent Finder

Xanthus Life Sciences, Inc.

Also on record
Records under this name other than patents Xanthus Life Sciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Xanthus Life Sciences, Inc.

PatentTitleStatus Expires Confidence
US 6,989,390Amonafide salts
Formerly held
Lapsed on the fee record
Ended Jan 24, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jan 24, 2014From the USPTO record
US 6,740,305Assessment of gastric emptying disorders
Lapsed on the fee record
Ended May 25, 2012 · From the USPTO record
Lapsed on the fee recordEnded May 25, 2012From the USPTO record
US 6,693,198Amonafide salts
Formerly held
Lapsed on the fee record
Ended Feb 17, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 17, 2012From the USPTO record
US 6,610,270In vivo determination of metabolic function for use in therapy management
Lapsed on the fee record
Ended Aug 26, 2011 · From the USPTO record
Lapsed on the fee recordEnded Aug 26, 2011From the USPTO record
US 6,284,219In vivo determination of metabolic function for use in therapy management
Lapsed on the fee record
Ended Sep 4, 2009 · From the USPTO record
Lapsed on the fee recordEnded Sep 4, 2009From the USPTO record
US 6,846,842Pyruvate Ester Composition and Method of Use for Resuscitation After Events of Ischemia and Reperfusion
Lapsed on the fee record
Ended Jan 25, 2009 · Medium confidence
Lapsed on the fee recordEnded Jan 25, 2009Medium confidence
US 5,095,027Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
Term ended
Term ended no later than Mar 10, 2012 · Low confidence
Term endedTerm ended no later than Mar 10, 2012Low confidence
US 5,183,821Method for treating leukemias using N-(2-dimethylaminoethyl)-3-amino-1,8-naphthalimide for treating leukemias and solid tumors
Formerly held
Term ended
Term ended no later than Feb 2, 2013 · Low confidence
Term endedTerm ended no later than Feb 2, 2013Low confidence
US 5,208,249Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
Term ended
Term ended no later than May 4, 2013 · Low confidence
Term endedTerm ended no later than May 4, 2013Low confidence
US 5,306,724Method for preventing and treating atherosclerosis
Term ended
Term ended no later than Apr 26, 2014 · Low confidence
Term endedTerm ended no later than Apr 26, 2014Low confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited